Drugs@FDA document
RESTORIL Other Important Information from FDA · NDA 018163 ORIG-1
Drugs@FDA document · SPECGX LLC · Mar 16, 2007
Key facts
| Drug name | RESTORIL |
|---|---|
| Document type | Other Important Information from FDA |
| Application | NDA018163 |
| Submission | ORIG-1 |
| Company | SPECGX LLC |
| Document date | Mar 16, 2007 |
| FDA document | fda.gov |
At a glance
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: